M&A activity in the pharmaceutical industry in Italy increased in 2023

In value terms, M&A activity in Italy remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal volume increased by 40% in Q2 2023 versus the previous quarter and was 40% higher than in Q2 2022.

The top-ranked legal advisorss supporting these M&A deals in Italy Q2 2023 were BonelliErede; CMS Legal Services EEIG; CMS Legal Services EEIG – France with 1, 1, 1 deals respectively.

For further understanding of GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.

This content was updated on 18 July 2023

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.

FDA greenlights Orchard’s gene therapy Lenmeldy for rare and fatal disease

The FDA approved a gene therapy known as Lenmeldy for early-onset metachromatic leukodystrophy, or MLD, a rare and fatal genetic disease that leads the nervous

March 19, 2024

Clinical Challenges: Test Your Knowledge on Pediatric Vaccines

A MedPage Today Clinical Challenges series discussed three areas of pediatric vaccines: vaccinating children with needle phobia, handling vaccine hesitancy among parents, and navigating new

November 11, 2023

STAT+: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership

Next stop: Beacon Hill. Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus

March 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.